IP Library Granted Patent US 8,617,145
Granted Patent B2
US 8,617,145 · App. 12/358,033 · Granted Dec 31, 2013

Methods of treating a cardiac arrhythmia by thoracoscopic production of a Cox maze III lesion set

Inventor: James Longoria (Sacramento, CA)
Assignee: Intrepid Medical, Inc.
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 8,617,145
App. No.
12/358,033
Granted
Dec 31, 2013
Kind
B2
Abstract

Methods of treating a subject for a cardiac arrhythmia are provided. Aspects of the methods include thoracoscopically producing a cardiac Cox maze III set of lesions in cardiac tissue of the subject in a manner sufficient to treat the subject for the cardiac arrhythmia.

Claims (26)

1. A method of treating a subject for cardiac arrhythmia, the method comprising thoracoscopically producing a Cox maze III set of lesions in a manner sufficient to treat the subject for the cardiac arrhythmia, wherein the Cox maze III set of lesions comprises a right pulmonary vein encircling ablation line, a left pulmonary vein encircling ablation line, a superior connecting ablation line connecting the right and left pulmonary vein encircling lines, and an inferior connecting ablation line connecting the right and left pulmonary vein encircling lines.

2. The method according to claim 1 , wherein thoracoscopically producing comprises making a thoracoscopic body opening that measures no more than 12 millimeters in greatest dimension.

3. The method according to claim 2 , wherein the method comprises intraoperative testing to confirm the presence of a lesion.

4. The method according to claim 1 , wherein at least one lesion comprises a transmural lesion.

5. The method according to claim 1 , wherein the method further comprises thoracoscopically producing a lesion in a ganglionic plexus.

6. The method according to claim 2 , wherein thoracoscopically producing comprises making bilateral thoracoscopic body openings.

7. The method according to claim 6 , wherein the bilateral thoracoscopic body openings comprise four thoracoscopic body openings on each side.

8. The method according to claim 2 , wherein the thoracoscopic body opening is an opening in a second intercostal space.

9. The method according to claim 2 , wherein the thoracoscopic body opening is an opening in a third intercostal space medial to the anterior axillary line.

10. The method according to claim 1 , wherein the Cox maze III set of lesions further comprises an ablation line connecting the superior connecting ablation line to the base of the left atrial appendage.

11. The method according to claim 1 , wherein the Cox maze III set of lesions further comprises a left atrial appendectomy.

12. The method according to claim 1 , wherein the Cox maze III set of lesions further comprises an ablation line connecting the superior connecting ablation line to the fibrous trigone.

13. The method according to claim 1 , wherein the Cox maze III set of lesions further comprises an ablation line extending from the inferior connecting ablation line to the coronary sinus.

14. The method according to claim 1 , wherein the Cox maze III set of lesions further comprises an ablation line in the posterolateral wall of the right atrium connecting the superior vena cava to the inferior vena cava.

15. The method according to claim 1 , wherein the Cox maze III set of lesions further comprises an ablation line from the right pulmonary vein encircling ablation line to the posterolateral wall of the right atrium.

16. The method according to claim 1 , wherein the Cox maze III set of lesions further comprises focal ablation of a complex fractionated atrial electrogram.

17. The method according to claim 1 , wherein thoracoscopically producing comprises contacting cardiac tissue with an ablation device.

18. The method according to claim 17 , wherein the ablation device is a clamping device.

19. The method according to claim 17 , wherein the ablation device is an elongated cylindrical device.

20. The method according to claim 17 , wherein the ablation device is a bipolar radiofrequency device.

21. The method according to claim 17 , wherein the ablation device is a laser energy device.

22. The method according to claim 17 , wherein the ablation device is a microwave energy device.

23. The method according to claim 17 , wherein the ablation device is a thermal energy device.

24. The method according to claim 17 , wherein the ablation device is an ultrasound device.

25. The method according to claim 17 , wherein the ablation device is a cryoablation device.

26. The method according to claim 1 , wherein the cardiac arrhythmia comprises atrial fibrillation.

Assignments (5)
SECURITY INTEREST Recorded Jan 10, 2024
From: ATRICURE, INC.; ATRICURE, LLC.
To: JPMORGAN CHASE BANK, N.A., AS ADMINISTRATIVE AGENT
Reel/Frame 066267/0896 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Sep 22, 2021
From: CHARLES SOMERS LIVING TRUST
To: ATRICURE, INC.
Reel/Frame 057560/0008 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jun 3, 2020
From: LC THERAPEUTICS, INC.
To: CHARLES SOMERS LIVING TRUST
Reel/Frame 052826/0871 →
CHANGE OF NAME Recorded Dec 11, 2013
From: INTREPID MEDICAL, INC.
To: LC THERAPEUTICS, INC.
Reel/Frame 031796/0630 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Aug 19, 2013
From: LONGORIA, JAMES
To: INTREPID MEDICAL, INC.
Reel/Frame 031039/0971 →
Continuity (2)
Provisional Application 61023811 · Jan 25, 2008
Related Publication 20100185186A1 · Jul 22, 2010